NCT04264767 is a clinical trial of Blood collection in Cancer, sponsored by Nucleix Ltd..

Who is sponsoring NCT04264767?

NCT04264767 is sponsored by Nucleix Ltd..

What drugs are being tested in NCT04264767?

Interventions in NCT04264767: Blood collection.

What condition does NCT04264767 study?

NCT04264767 studies Cancer, Solid Tumor, Hematologic Neoplasms.

Is NCT04264767 still recruiting?

NCT04264767 is currently completed. Last updated 8 June 2022.

Last reviewed 2022-06-08 · How we verify

NCT04264767

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA

Completed Last updated 8 June 2022

What this trial tests

trial testing Blood collection in Cancer in 800 participants. Completed in 30 January 2021.

Timeline

17 April 2019

Primary endpoint
30 January 2021

30 January 2021

Quick facts

Lead sponsor	Nucleix Ltd.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	800
Start date	17 April 2019
Primary completion	30 January 2021
Estimated completion	30 January 2021
Sites	3 locations across United States, Israel

Drugs / interventions tested

Blood collection — full drug profile →

Conditions studied

Cancer — all drugs for Cancer →
Solid Tumor — all drugs for Solid Tumor →
Hematologic Neoplasms — all drugs for Hematologic Neoplasms →

Sponsor

Nucleix Ltd.

Who can join

Adults 22 to 80, any sex, with Cancer or Solid Tumor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Nucleix EpiCheck® tests analyzes the methylation pattern in a panel of DNA methylation biomarkers and determines whether this pattern is consistent with cancer under test or with non-cancer tissue. This study is being performed as part of the development process of the Pan Cancer EpiCheck test which includes the identification of different methylation profiles in various cancer types and healthy controls.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Liquid Biopsy in Cancer: Focus on Lymphoproliferative Disorders.
Savino FD, Rigali F, Giustini V, D'Aliberti D, et al · · 2022 · cited 6× · PMID 36358796 · DOI 10.3390/cancers14215378

Verify or expand the search:

Other trials of Blood collection

Trials testing the same drug.

NCT07134491 — Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, · recruiting
NCT07075107 — Transcriptomic Analysis of Fibroblasts and Blood in Patients With Rare Diseases · NA · not yet recruiting
NCT06510868 — Evaluating Myelodysplastic Syndrome Risks in NET Patients Planned for Peptide Radionuclide Therapy · recruiting
NCT06521502 — The APS Phenotyping Study · recruiting
NCT06373510 — Longitudinal Evaluation of Antibody Kinetics of Vaccinated Patients With Non-mandatory Vaccine Following Administration · NA · not yet recruiting

Other recruiting trials for Cancer

Currently open trials in the same condition.

NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting

Other Nucleix Ltd. trials

Trials by the same sponsor.

NCT06245876 — Lung EpiCheck Biomarkers Development Study · unknown
NCT06020807 — Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evid · completed
NCT04264754 — Characterization of Methylation Patterns in Hepatocellular Carcinoma · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04264767 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nucleix Ltd.
Last refreshed: 8 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04264767.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing